MLchartDataset catalogue

Esorubicin

Term · Oncology and biomedicine · MLC-T-ONC-013433

A synthetic derivative of the anthracycline antineoplastic antibiotic doxorubicin with potential antineoplastic activity. Esorubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent exhibits less cardiotoxicity than the parent antibiotic doxorubicin, but may cause more severe myelosupression compared to other compounds within the anthracycline class.

Table 1. Record
IdentifierMLC-T-ONC-013433
FieldOncology and biomedicine
Synonymsdeoxydoxorubicin; deoxyadriamycin hydrochloride; deoxyadriamycin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013433",
  "term": "Esorubicin",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic derivative of the anthracycline antineoplastic antibiotic doxorubicin with potential antineoplastic activity. Esorubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent exhibits less cardiotoxicity than the parent antibiotic doxorubicin, but may cause more severe myelosupression compared to other compounds within the anthracycline class.",
  "synonyms": [
    "deoxydoxorubicin",
    "deoxyadriamycin hydrochloride",
    "deoxyadriamycin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/esorubicin/"
}

Record 6,910 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.